Skip To Main Content
Stephen J. Kent on Muck Rack

Stephen J. Kent

As seen in: Color Research & Application, Nature, USA Today, The Hill, Pursuit, Royal Society of Chemistry, Washington Examiner, BioRxiv, Cell Press, The Lancet and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Stephen J.

Contact Stephen J., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Atypical B cells and inflammatory profiles delineate immunity to influenza vaccination in First Nations and non-Indigenous people with chronic multimorbidity

|
By Morgan Skinner, Lukasz Kedzierski, Ruth Purcell, Mark Mayo, Bianca F. Middleton, Lilith F Allen, Ruth R. Hagen, Matilda Clark, Caitlin Kent, Malet Aban, Heidi A. Peck, Hayley A. McQuilten, Arnold Reynaldi, Ashleigh Holloway, Angelica Tan, Vanessa Rigas, Miles P Davenport, Stephen J. Kent, Ian Barr, Hyon-Xhi Tan, Adam K. Wheatley, Amy Chung, Jane Nelson, Adrian Miller, Thi Nguyen, Jane Davies, Louise C. Rowntree, Katherine Kedzierska, Alexandra Hinchcliff, Erin Gargen
| Nature Verified
Abstract Indigenous people are disproportionately impacted by influenza viruses and chronic multimorbidity. Yet, the impact of comorbidities on immunity towards influenza vaccination is unknown. We recruited Australian First Nations and non-Indigenous people vaccinated with seasonal inactivated influenza vaccines and assessed their humoral and cellular responses in the context of comorbidities at baseline and after immunisation.
Open in Who Shared Issue with article?

Impact of serum versus anticoagulant-containing plasma on influenza virus neuraminidase-based serological assays

|
By Thu Trang Do, Stephen J. Kent, Adam K. Wheatley, Marios Koutsakos
| BioRxiv
Abstract The influenza virus neuraminidase (NA) is a promising target for next-generation influenza vaccines but standardized protocols for NA-based serological assays are lacking. Previous studies have demonstrated discordant results from haemagglutination inhibition and live virus microneutralization assays when comparing matched serum and plasma samples. It is therefore important to consider is the choice of serum or plasma samples in assays measuring influenza virus NA-specific antibodies.
Open in Who Shared Issue with article?

Towards evidence-based immunology - Nature Immunology

|
By David Khoury, Deborah Cromer, Bronwyn Bailey, Deborah L. Burnett, Stephen J. Kent, Brian Rudd
| Nature Verified
Immunology is in an unprecedented era of exciting exploration, made possible by powerful new tools and technologies. To capitalize on this progress and translate discovery to meaningful impact, a parallel culture of ‘evidence-based immunology’ must be developed.
Open in Who Shared Issue with article?
See all 78 articles